Multiple effects of sibutramine on ejaculation and on vas deferens and seminal vesicle contractility

Toxicology and Applied Pharmacology

Volumn 239, Issue 3, 2009, Pages 233-240

  Nojimoto, Fernanda D ^a   Piffer, Renata C ^a   Kiguti, Luiz Ricardo de A ^a   Lameu, Claudiana ^b   de Camargo, Antônio C M ^b   Pereira, Oduvaldo C M ^a   Pupo, André S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Abnormal ejaculation; Premature ejaculation; Seminal vesicle; Sibutramine; Vas deferens

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CALCIUM CHLORIDE; CALCIUM ION; CARBACHOL; MUSCARINIC RECEPTOR; NORADRENALIN; SIBUTRAMINE;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; EJACULATION DISORDER; HUMAN; HUMAN CELL; IN VITRO STUDY; LATENT PERIOD; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; RAT; SEMINAL VESICLE; SMOOTH MUSCLE CONTRACTILITY; VAS DEFERENS;

ANIMALS; APPETITE DEPRESSANTS; CALCIUM; CALCIUM CHLORIDE; CARBACHOL; CELL LINE; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; EJACULATION; FEMALE; HUMANS; ISOMETRIC CONTRACTION; MALE; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, MUSCARINIC; SEMINAL VESICLES; VAS DEFERENS;

RATTUS;

EID: 69049101015     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.05.021     Document Type: Article

References (24)

1. Agmo A. Male rat sexual behavior. Brain Res. Brain Res. Protoc. 1 (1997) 203-209
2. Arunlakshana O., and Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14 (1959) 48-58
3. Bray G.A. A concise review on the therapeutics of obesity. Nutrition 16 (2000) 953-960
4. Campos M., de Lucena Morais P., and Pupo A.S. Functional characterisation of alpha(1)-adrenoceptors in denervated rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 368 (2003) 72-78
5. Gerardin D.C., Pereira O.C., Kempinas W.G., Florio J.C., Moreira E.G., and Bernardi M.M. Sexual behavior, neuroendocrine, and neurochemical aspects in male rats exposed prenatally to stress. Physiol. Behav. 84 (2005) 97-104
6. Giuliano F. 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention. Trends Neurosci. 30 (2007) 79-84
7. Giuliano F., and Clement P. Serotonin and premature ejaculation: from physiology to patient management. Eur. Urol. 50 (2006) 454-466
8. Halpern A., and Mancini M.C. Treatment of obesity: an update on anti-obesity medications. Obes. Rev. 4 (2003) 25-42
9. Harhun M.I., Jurkiewicz A., Jurkiewicz N.H., Kryshtal D.O., Shuba M.F., and Vladimirova I.A. Voltage-gated potassium currents in rat vas deferens smooth muscle cells. Pflugers Arch. 446 (2003) 380-386
10. Jackson H.C., Bearham M.C., Hutchins L.J., Mazurkiewicz S.E., Needham A.M., and Heal D.J. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br. J. Pharmacol. 121 (1997) 1613-1618
11. Kim S.E., Ahn H.S., Choi B.H., Jang H.J., Kim M.J., Rhie D.J., Yoon S.H., Jo Y.H., Kim M.S., Sung K.W., and Hahn S.J. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine. J. Pharmacol. Exp. Ther. 321 (2007) 753-762
12. McMahon C.G., Abdo C., Incrocci L., Perelman M., Rowland D., Waldinger M., and Xin Z.C. Disorders of orgasm and ejaculation in men. J. Sex Med. 1 (2004) 58-65
13. Ohya S., Tanaka M., Oku T., Asai Y., Watanabe M., Giles W.R., and Imaizumi Y. Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel alpha-subunit, Kv4.3 in the rat. FEBS Lett. 420 (1997) 47-53
14. Padwal R.S., and Majumdar S.R. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369 (2007) 71-77
15. Park J.Y., Kim K.A., Park P.W., Suh K.H., and Lee G.S. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study. Clin. Ther. 26 (2004) 2092-2101
16. Pupo A.S. Functional effects of castration on alpha1-adrenoceptors in rat vas deferens. Eur. J. Pharmacol. 351 (1998) 217-223
17. Pupo A.S., Cavenaghi D.L., Campos M., Lucena Morais P., Jurkiewicz N.H., and Jurkiewicz A. Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade. Br. J. Pharmacol. 127 (1999) 1832-1836
18. Roth J.D., Trevaskis J.L., Wilson J., Lei C., Athanacio J., Mack C., Kesty N.C., Coffey T., Weyer C., and Parkes D.G. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. Int. J. Obes. (Lond). 32 (2008) 1201-1210
19. Sanbe A., Tanaka Y., Fujiwara Y., Tsumura H., Yamauchi J., Cotecchia S., Koike K., Tsujimoto G., and Tanoue A. Alpha1-adrenoceptors are required for normal male sexual function. Br. J. Pharmacol. 152 (2007) 332-340
20. Seo K.K., Kim S.C., and Lee M.Y. Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies. J. Urol. 165 (2001) 2110-2114
21. Trendelenburg U., Maxwell R.A., and Pluchino S. Methoxamine as a tool to assess the importance of intraneuronal uptake of l-norepinephrine in the cat's nictitating membrane. J. Pharmacol. Exp. Ther. 172 (1970) 91-99
22. Triggle D.J., and Swamy V.C. Calcium antagonists. Some chemical-pharmacologic aspects. Circ. Res. 52 (1983) I17-28
23. Um S.Y., Kim K.B., Kim S.H., Ju Y.C., Lee H.S., Oh H., Choi K.H., and Chung M.W. Determination of the active metabolites of sibutramine in rat serum using column-switching HPLC. J. Sep. Sci. 31 (2008) 2820-2826
24. Wellman P.J., Miller D.K., and Ho D.H. Noradrenergic modulation of ephedrine-induced hypophagia. Synapse 48 (2003) 18-24